highmark glp-1 coverage Weight Loss Drugs versus Bariatric Surgery for Obesity Treatment Ro launches GLP-1 insurance coverage

Most patients experience their most noticeable changes after the 12 to 16-week mark

According to the World Health Organization, obesity prevalence has nearly tripled since 1975, and it is associated with increased risks of developing chronic diseases such as type 2 diabetes, cardiovascular disease, and certain types of cancer

Your doctor will typically provide you with guidance on how to manage particular side effects during Ozempic therapy

To date, liraglutide, and the more effective once-weekly semaglutide, have been approved in the US and Europe for the treatment of obesity, with unprecedented weight loss of up to 1520%

GLP-1 receptors are expressed primarily in pancreatic islets, the gastrointestinal tract, kidney, heart, and certain brain regions, with limited expression in skeletal muscle tissue

Liu H, Zhang S, Zhou Z, Xing M, Gao Y